Palantir: Surging Insider Sales Are A Red Flag (Rating Downgrade)

Summary:

  • Palantir shares have surged 115% YTD due to AI-driven platform gains, strong customer acquisition, and improved fundamentals, but now seem highly priced.
  • Recent insider sales, including 9M shares by CEO Alexander Karp, have surged, signaling potential overvaluation and warranting investor caution.
  • AIP momentum is still solid, however, as the company just announced a new contract from the DEVCOM Army Research Laboratory, worth up to $100M over five years.
  • Palantir’s valuation now exceeds my fair value estimate of $31.40 per share by 18%, prompting a downgrade to hold.
  • Risks include potential slowdowns in AI spending, which could impact customer acquisition and free cash flow growth, necessitating careful investor consideration.

Words Insider Selling on yellow finance background from graphs, charts. Trend Up and Down. 3D render

Vladimir Zakharov

Shares of Palantir (NYSE:PLTR) have soared to new 1-year highs recently, on general optimism about AI-driven platform gains. Year-to-date, Palantir’s share price has increased 115% as the company’s fundamentals considerably improved due to strong customer acquisition momentum, growing operating income and


Analyst’s Disclosure: I/we have a beneficial long position in the shares of PLTR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *